Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 4,922	$ 8,695
Cost of revenue	4,063	6,261
Gross profit	859	2,434
Operating expenses:
Research and development	746	602
Selling	419	419
General and administrative	1,317	1,600
Total operating expenses	2,482	2,621
Operating loss	(1,623)	(187)
Other income (expense):
Interest income	157	120
Interest expense	(6)	(6)
Foreign exchange income		27
Other income		8
Total other income, net	151	149
Loss before income taxes	(1,472)	(38)
Income tax expense		2
Net loss	$ (1,472)	$ (40)
Loss per common share - basic	$ (0.22)	$ (0.01)
Loss per common share - diluted	$ (0.22)	$ (0.01)
Weighted average common shares outstanding:
Basic	6,809,283	6,773,285
Diluted	6,809,283	6,773,285